Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
PaperCitations, authors & open-access status
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2,070 citations, 2019 year and bronze oa status.
2,070
Citations
2019
Year
bronze
OA Status